Security key
31189P102
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q3 2014 13F Holders as of 30 Sep 2014
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 10,270,522
- Share change
- +416,558
- Total reported value
- $52,580,000
- Price per share
- $5.10
- Number of holders
- 22
- Value change
- +$2,082,379
- Number of buys
- 13
- Number of sells
- 7
Report period
Q3 2014
Institutions
22
Top holders
10
FATE full security history
Newer quarter: Q4 2014
Previous quarter: Q2 2014
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
2.5%
|
3,053,573
|
$19,268,000 | — | 30 Jun 2014 | |
| Polaris Venture Management Co. V, L.L.C. |
13F
|
Company |
2%
|
2,473,186
|
$15,606,000 | — | 30 Jun 2014 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.98%
|
1,197,675
|
$7,797,000 | — | 30 Jun 2014 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.98%
|
1,194,010
|
$7,533,000 | — | 30 Jun 2014 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.57%
|
692,900
|
$4,372,000 | — | 30 Jun 2014 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.24%
|
292,567
|
$1,846,000 | — | 30 Jun 2014 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.2%
|
248,102
|
$1,566,000 | — | 30 Jun 2014 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.17%
|
204,000
|
$1,287,000 | — | 30 Jun 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.12%
|
148,606
|
$938,000 | — | 30 Jun 2014 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.06%
|
75,930
|
$479,000 | — | 30 Jun 2014 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
67,877
|
$428,000 | — | 30 Jun 2014 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.04%
|
51,077
|
$322,000 | — | 30 Jun 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.03%
|
38,400
|
$242,000 | — | 30 Jun 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
24,701
|
$154,000 | — | 30 Jun 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
0.02%
|
23,831
|
$150,000 | — | 30 Jun 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
23,664
|
$149,000 | — | 30 Jun 2014 | |
| BOURGEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.01%
|
15,384
|
$97,000 | — | 30 Jun 2014 | |
| DG CAPITAL MANAGEMENT INC |
13F
|
Company |
0.01%
|
12,935
|
$82,000 | — | 30 Jun 2014 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.01%
|
12,200
|
$77,000 | — | 30 Jun 2014 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
2,073
|
$13,000 | — | 30 Jun 2014 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
646
|
$4,000 | — | 30 Jun 2014 | |
| Ground Swell Capital, LLC |
13F
|
Company |
0%
|
100
|
$1,000 | — | 30 Jun 2014 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q3 2014
As of 30 Sep 2014,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,270,522 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., KINGDON CAPITAL MANAGEMENT, L.L.C., WELLINGTON MANAGEMENT CO LLP, ORBIMED ADVISORS LLC, Board of Trustees of The Leland Stanford Junior University, PRINCIPAL FINANCIAL GROUP INC, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, and GOLDMAN SACHS GROUP INC.
This page lists
22
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2014 vs Q2 2014 Across Filers
Q2 2014 holders
21
Q3 2014 holders
22
Holder diff
1
| Investor | Q2 2014 Shares | Q3 2014 Shares | Share Diff | Share Chg % | Q2 2014 Value $ | Q3 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.